Motilal Oswal BSE Healthcare ETF - Growth - Regular Plan

  • Previous Nav

  • Net Change on 10-12-2025

  • PersonalFN Rating

  • Category

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the Constituents of S&P BSE Healthcare Index, subject to tracking error.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
UTI Nifty 50 ETF Sep 01, 2015 6.24 13.02 15.10 0.05 69,510.29
Nippon India ETF Nifty 50 BeES Dec 28, 2001 6.22 13.02 15.11 0.04 55,666.38
UTI BSE Sensex ETF Sep 01, 2015 5.08 12.15 14.22 0.05 54,591.09
Nippon India ETF BSE Sensex Sep 24, 2014 5.07 12.18 14.23 0.04 23,014.20
Nippon India ETF Nifty Bank BeES May 27, 2004 11.54 11.43 14.64 0.19 8,029.73

Fund Holdings as on 30-November-2025

  • Sun Pharmaceutical Industries Limited

  • Max Healthcare Institute Limited

  • Cipla Limited

  • Divi's Laboratories Limited

  • Dr. Reddy's Laboratories Limited

  • Apollo Hospitals Enterprise Limited

  • Lupin Limited

  • Fortis Healthcare Limited

  • Laurus Labs Limited

  • Torrent Pharmaceuticals Limited

  • Aurobindo Pharma Limited

  • Alkem Laboratories Limited

  • Glenmark Pharmaceuticals Limited

  • Mankind Pharma Limited

  • Biocon Limited

  • Zydus Lifesciences Limited

  • IPCA Laboratories Limited

  • Krishna Institute Of Medical Sciences Limited

  • Abbott India Limited

  • Neuland Laboratories Limited

  • Aster DM Healthcare Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Gland Pharma Limited

  • Narayana Hrudayalaya Limited

  • Syngene International Limited

  • Dr. Lal Path Labs Limited

  • Piramal Pharma Limited

  • Ajanta Pharma Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Global Health Limited

  • Wockhardt Limited

  • Acutaas Chemicals Limited

  • Jubilant Pharmova Limited

  • Sai Life Sciences Limited

  • Onesource Specialty Pharma Limited

  • Granules India Limited

  • Natco Pharma Limited

  • Pfizer Limited

  • Poly Medicure Limited

  • Cohance Lifesciences Limited

  • Rainbow Childrens Medicare Limited

  • Eris Lifesciences Limited

  • Strides Pharma Science Limited

  • AstraZeneca Pharma India Limited

  • Jupiter Life Line Hospitals Limited

  • Indegene Limited

  • Metropolis Healthcare Limited

  • Alembic Pharmaceuticals Limited

  • Vijaya Diagnostic Centre Limited

  • Concord Biotech Limited

  • Procter & Gamble Health Limited

  • Dr Agarwals Health Care Limited

  • Marksans Pharma Limited

  • Sanofi India Limited

  • Caplin Point Laboratories Limited

  • Healthcare Global Enterprises Limited

  • Shilpa Medicare Limited

  • Aarti Pharmalabs Limited

  • Emcure Pharmaceuticals Limited

  • Sanofi Consumer Healthcare India Limited

  • Kovai Medical Center and Hospital Limited

  • Alivus Life Sciences Limited

  • Sequent Scientific Limited

  • Yatharth Hospital And Trauma Care Services Limited

  • Thyrocare Technologies Limited

  • Indraprastha Medical Corporation Limited

  • Senores Pharmaceuticals Limited

  • FDC Limited

  • Supriya Lifescience Limited

  • Net Receivables / (Payables)

  • Dishman Carbogen Amcis Limited

  • Morepen Laboratories Limited

  • Solara Active Pharma Sciences Limited

  • Krsnaa Diagnostics Limited

  • Aarti Drugs Limited

  • Advanced Enzyme Technologies Limited

  • Blue Jet Healthcare Ltd

  • Gujarat Themis Biosyn Limited

  • Sun Pharma Advanced Research Company Limited

  • Orchid Pharma Limited

  • Innova Captab Limited

  • Akums Drugs and Pharmaceuticals Limited

  • Bliss GVS Pharma Limited

  • IOL Chemicals and Pharmaceuticals Limited

  • Suven Life Sciences Limited

  • RPG Life Sciences Limited

  • Unichem Laboratories Limited

  • Gufic Biosciences Limited

  • Indoco Remedies Limited

  • SMS Pharmaceuticals Limited

  • Vimta Labs Limited

  • Artemis Medicare Services Limited

  • Hikal Limited

  • Dr.Agarwals Eye Hospital Limited

  • Syncom Formulations India Limited

  • Sigachi Industries Limited

  • 3B BlackBio Dx Limited

  • Windlas Biotech Limited

  • Hester Biosciences Limited

  • Panacea Biotec Limited

  • Suraksha Diagnostic Limited

  • Shalby Limited

  • Novartis India Limited

  • Wanbury Limited

  • Fischer Medical Ventures Limited

  • Lincoln Pharmaceuticals Limited

  • Laxmi Dental Limited

  • Kwality Pharmaceuticals Limited

  • Jagsonpal Pharmaceuticals Limited

  • GPT Healthcare Limited

  • Bajaj Healthcare Limited

  • Kopran Limited

  • Tarsons Products Limited

  • Themis Medicare Limited

  • KMC Speciality Hospitals (India) Limited

  • Fermenta Biotech Limited

  • Sastasundar Ventures Limited

  • Anuh Pharma Limited

  • Nectar Lifesciences Limited

  • Shree Ganesh Remedies Limited

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

  • Chemicals

  • Pesticides & Agrochemicals

  • Trading

  • Plastic Products

  • Finance - NBFC

View More

Fund Manager

  • Cash

  • Equity

View More

About Motilal Oswal BSE Healthcare ETF

Scheme Analysis

Motilal Oswal BSE Healthcare ETF is a ETFs - Index fund and belongs to Motilal Oswal Mutual Fund. It was launched on 29-Jul-2022 and currently has an AUM of ₹38.10 crore. Motilal Oswal BSE Healthcare ETF is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Motilal Oswal BSE Healthcare ETF ended down ₹-0.05(-0.11%)yesterday to ₹44.1762.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Motilal Oswal BSE Healthcare ETF is managed by Swapnil P Mayekar and Rakesh Shetty.

Fund House Contact

10th Floor, Motilal Oswal Tower, Rahimtullah Sayani Road, Opp Parel ST Bus Depot, Prabhadevi Mumbai - 400025

022 40548002
amc@motilaloswal.com
022-22816161